Modification of disodium cromoglycate passage across lung epithelium in vitro via incorporation into polymeric microparticles

AAPS Journal

Volumn 14, Issue 1, 2012, Pages 79-86

  Haghi, Mehra ^a   Salama, Rania ^a   Traini, Daniela ^a   Bebawy, Mary ^b   Young, Paul M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Calu 3; controlled release; disodium cromoglycate; dry powder inhaler; DSCG

Indexed keywords

CROMOGLYCATE DISODIUM; POLYVINYL ALCOHOL;

AEROSOL; ARTICLE; CANCER CELL CULTURE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; PARTICLE SIZE; POWDER INHALER; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ADMINISTRATION, INHALATION; AEROSOLS; ANTI-ASTHMATIC AGENTS; CELL LINE; CROMOLYN SODIUM; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIUM; HUMANS; LUNG; MICROSPHERES; PARTICLE SIZE; POLYVINYL ALCOHOL; POWDERS; TIME FACTORS;

EID: 84857624965     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-011-9317-2     Document Type: Article

References (29)

1. D Bilton P Bruinenberg B Otulana R Morishige J Blanchard A DeSoyza, et al. 2009 Inhaled liposomal ciprofloxacin hydrochloride significantly reduces sputum Pseudomonas aeruginosa density in CF and non-CF bronchiectasis Am J Respir Crit Care Med 179 A3214
2. KMG Taylor G Taylor IW Kellaway J Stevens 1989 The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man Pharm Res 6 7 633 636 2508078 10.1023/A:1015917918130 1:CAS:528:DyaL1MXlt1Sktro%3D (Pubitemid 19214431)
3. R Salama 2009 Recent advances in controlled release pulmonary therapy Curr Drug Deliv 6 4 404 414 19534707 10.2174/156720109789000546 1:CAS:528:DC%2BD1MXhtFKksrzP
4. XM Zeng GP Martin C Marriott 1995 The controlled delivery of drugs to the lung Int J Pharm 124 2 149 164 10.1016/0378-5173(95)00104-Q 1:CAS:528:DyaK2MXnslygsr0%3D
5. RO Salama D Traini H-K Chan PM Young 2008 Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols Eur J Pharm Biopharm 70 1 145 152 18534832 10.1016/j.ejpb.2008.04.009 1:CAS:528:DC%2BD1cXhtVOitrjM
6. R Salama S Hoe H-K Chan D Traini PM Young 2008 Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 1: influence of polymer concentration on physical and in vitro characteristics Eur J Pharm Biopharm 69 2 486 495 18226880 10.1016/j.ejpb.2007.12.019 1:CAS:528:DC%2BD1cXmtVShu7c%3D
7. Online databese Stationery Office. British Pharmacopoeia Volumes I & II, Part II, Official Standards, Solubility. London. 2011. http://www. pharmacopoeia.co.uk. Accessed 12 June 2011.
8. R Salama L Ladd H-K Chan D Traini P Young 2009 Development of an in vivo ovine dry powder inhalation model for the evaluation of conventional and controlled release microparticles AAPS J 11 3 465 468 19568940 10.1208/s12248-009-9125-0 1:CAS:528:DC%2BD1MXhsFGmur7N
9. A Yamamoto K Yamada H Muramatsu A Nishinaka S Okumura N Okada, et al. 2004 Control of pulmonary absorption of water-soluble compounds by various viscous vehicles Int J Pharm 282 1-2 141 149 15336389 10.1016/j.ijpharm.2004.06. 008 1:CAS:528:DC%2BD2cXntVGhsLs%3D (Pubitemid 39178491)
10. KA Foster ML Avery M Yazdanian KL Audus 2000 Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery Int J Pharm 208 1-2 1 11 11064206 10.1016/S0378-5173(00)00452-X 1:CAS:528:DC%2BD3cXosVGjsbw%3D
11. M Bur B Rothen-Rutishauser H Huwer C-M Lehr 2009 A novel cell compatible impingement system to study in vitro drug absorption from dry powder aerosol formulations Eur J Pharm Biopharm 72 2 350 357 18771729 10.1016/j.ejpb.2008.07. 019 1:CAS:528:DC%2BD1MXmtVOjtb0%3D
12. JL Sporty L Horalkova C Ehrhardt 2008 In vitro cell culture models for the assessment of pulmonary drug disposition Expert Opin Drug Metab Toxicol 4 4 333 345 18433340 10.1517/17425255.4.4.333 1:CAS:528:DC%2BD1cXltVWmsbc%3D (Pubitemid 351728510)
13. C Grainger L Greenwell D Lockley G Martin B Forbes 2006 Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier Pharm Res 23 7 1482 1490 16779708 10.1007/s11095-006-0255-0 1:CAS:528:DC%2BD28XmsFOmtbg%3D (Pubitemid 43993811)
14. CA Fernandes R Vanbever 2009 Preclinical models for pulmonary drug delivery Expert Opin Drug Deliv 6 1231 1245 19852680 10.1517/17425240903241788 1:CAS:528:DC%2BD1MXhtlWlsb7M
15. NR Mathias F Yamashita VHL Lee 1996 Respiratory epithelial cell culture models for evaluation of ion and drug transport Adv Drug Deliv Rev 22 1-2 215 249 10.1016/S0169-409X(96)00420-6 1:CAS:528:DyaK28Xnt1KlsrY%3D (Pubitemid 26423603)
16. M Haghi PM Young D Traini R Jaiswal J Gong M Bebawy 2010 Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model Drug Dev Ind Pharm 36 10 1207 1214 20374185 10.3109/03639041003695113 1:CAS:528:DC%2BC3cXhtFWiurrI
17. S Endter D Francombe C Ehrhardt M Gumbleton 2009 RT-PCR Analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models J Pharm Pharmacol 61 5 583 591 19405996 10.1211/jpp.61.05.0006 1:CAS:528: DC%2BC3cXmtVemsg%3D%3D
18. B Forbes C Ehrhardt B Forbes C Ehrhardt 2005 Human respiratory epithelial cell culture for drug delivery applications Eur J Pharm Biopharm 60 2 193 205 15939233 10.1016/j.ejpb.2005.02.010 1:CAS:528:DC%2BD2MXltFCrsr8%3D (Pubitemid 40804561)
19. CI Grainger LL Greenwell GP Martin B Forbes 2009 The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa Eur J Pharm Biopharm 71 2 318 324 18845252 10.1016/j.ejpb.2008.09.006 1:CAS:528:DC%2BD1MXitVShsbc%3D
20. S Hein M Bur UF Schaefer C-M Lehr 2011 A new pharmaceutical aerosol deposition device on cell cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations Eur J Pharm Biopharm 77 1 132 138 20951200 10.1016/j.ejpb.2010.10.003 1:CAS:528:DC%2BC3cXhs1WktLjF
21. Online databese Stationery Office. British Pharmacopoeia, Appendix XII C London. 2011. http://www.pharmacopoeia.co.uk. Accessed 01 June 2011.
22. JN Pritchard 2001 The influence of lung deposition on clinical response J Aerosol Med 14 1 S19 S26 11424889 10.1089/08942680150506303 1:CAS:528:DC%2BD3MXhs1yktrc%3D
23. S Tolani 1975 A method for viable cell count Method Cell Sci 1 1 37 38
24. Z Xu HM Mansour T Mulder R McLean J Langridge AJ Hickey 2010 Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate J Pharm Sci 99 8 3398 3414 20198688 10.1002/jps.22107 1:CAS:528:DC%2BC3cXnvFGktbs%3D
25. S Jeong Kim S Jun Park I Young Kim Y Hee Lee SI Kim 2002 Thermal characteristics of poly(vinyl alcohol) and poly(vinylpyrrolidone) IPNs J Appl Polym Sci 86 8 1844 1847 10.1002/app.11096
26. JS Patton PR Byron 2007 Inhaling medicines: delivering drugs to the body through the lungs Nat Rev Drug Discov 6 1 67 74 17195033 10.1038/nrd2153 1:CAS:528:DC%2BD28XhtlGktbbL (Pubitemid 46020287)
27. Hartshorne NH, Woodard GD. Mesomorphism in the system disodium chromoglycate-water. In: Molecular crystals and liquid crystals. Great Britain: Gordon and Breach Science Publishers; 1973. p. 343-68.
28. JV Chamipon GH Meeten 1973 Conformation of sodium cromolyn in aqueous solution using light scattering and magnetic birefringence J Pharm Sci 62 10 1589 1595 10.1002/jps.2600621003
29. H Ong D Traini M Bebawy P Young 2011 Epithelial profiling of antibiotic controlled release respiratory formulations Pharm Res. 28 2327 2338 10.1007/s11095-011-0462-1 21614637 10.1007/s11095-011-0462-1 1:CAS:528:DC%2BC3MXmsFGnsrc%3D